The FDA has approved Oravig (miconazole) buccal tablets for the treatment of oropharyngeal candidiasis in adults and childen aged 16 years and older. The drug is the first and only local, oral ...
SAN ANTONIO, May 4 /PRNewswire-FirstCall/ -- Results of a Phase 3 clinical trial demonstrate positive results with a fentanyl effervescent buccal tablet (FEBT) in all ...
AUSTIN, TX—In a study presented at the American Pain Society’s 30th Annual Scientific Meeting, fentanyl buccal tablet (FBT) was shown to be more effective than traditional short-acting opioids (SAO) ...
In this study, the absorption profile of FBT was similar in cancer patients with and without mucositis. Maximum plasma fentanyl concentrations were achieved within 30 minutes in both populations, and ...
Management of breakthrough pain in patients with cancer who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain. Opioid-tolerant patients are those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results